Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis

Journal of Neurochemistry

Volumn 71, Issue 1, 1998, Pages 281-287

  Browne, Susan E ^a   Bowling, Allen C ^a   Baik, M Jay ^a   Gurney, Mark ^b   Brown Jr , Robert H ^a   Beal, M Flint ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b PFIZER INC   (United States)

Author keywords

Amyotrophic lateral sclerosis; Free radicals; Neurodegeneration; Oxidative damage; Superoxide dismutase

Indexed keywords

SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ELECTRON TRANSPORT; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FAMILIAL DISEASE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0031865772     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71010281.x     Document Type: Article

References (44)

1. Aoki M., Nakamura S., Itoyama T., Abe K., Ogasawara M., Matsubara Y., and Narisawa K. (1993) Mild ALS in Japan associated with novel SOD mutation. Nature Genet. 5, 323-324
2. Beal M. F., Ferrante R. J., Browne S. E., Matthews R. T., Kowall N. W., and Brown R. H. (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42, 646-654.
3. Beckman J. S., Carson M., Smith C. D., and Koppenol W. H. (1993) ALS, SOD and peroxynitrite. Nature 364, 584.
4. Bowling A. C., Schulz J. B., Brown R. H. Jr., and Beal M. F. (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322-2325.
5. Bradford M. D. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Brown R. H. Jr. (1995) Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80, 687-692.
7. Browne S. E., Bowling A. C., MacGarvey U., Baik M. J., Berger S. C., Muqit M. M. K., Bird E. D., and Beal M. F. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-659.
8. Bruijn L. I., Beal M. F., Becher M. W., Schulz J. B., Wong P. C., Price D. L., and Cleveland D. W. (1997) Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked Superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. USA 94, 7606-7611.
9. Curti D., Malaspina A., Facchetti G., Camana C., Mazzini L., Tosca P., Zerbi F., and Ceroni M. (1996) Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 47, 1060-1064.
10. Dal Canto M. C. and Gurney M. E. (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145, 1271-1280.
11. Darley-Usmar V. M., Rickwood D., and Wilson M. T. (1987) Mitochondria: A Practical Approach. IRL Press, Oxford.
12. Deng H.-X., Hentati A., Tainer J. A., Iqbal Z., Cayabyab A., Hung W.-Y., Getzoff E. D., Hu P., Herzfeldt B., Roos R. P., Warner C., Deng G., Soriano E., Smyth C., Parge H. E., Ahmed A., Roses A. D., Hallewell R. A., Pericak-Vance M. A., and Siddique T. (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn Superoxide dismutase. Science 261, 1047-1051.
13. Elshafev A., Lanvon W. G., and Connor J. M. (1994) Identification of a new missense point mutation in exon 4 of the Cu,Zn superoxide dismutase (SOD) gene in a family with amyotrophic lateral sclerosis. Hum. Mol. Genet. 3, 363-364.
14. Ferrante R. J., Shinobu L. A., Schulz J. B., Matthews R. T., Thomas C. E., Kowall N. W., Gurney M. E., and Beal M. F. (1997) Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc Superoxide dismutase mutation. Ann. Neurol. 42, 326-334.
15. Fujita K., Yamauchi M., Shibayama K., Ando M., Honda M., and Nagata Y. (1996) Decreased cytochrome oxidase activity but unchanged Superoxide dismutase activities in the spinal cords of patients with amyotrophic lateral sclerosis. J. Neurosci. Res. 45, 276-281.
16. Gurney M. F., Pu H., Chiu A. Y., Dal Canto M. C., Polchow C. Y., Alexander D. D., Caliendo J., Hentati A., Kwon Y. W., Deng H.-X., Chen W., Zhai P., Sufit R. L., and Siddique T. (1994) Motor neuron degeneration in mice that express a human Cu,Zn Superoxide dismutase mutation. Science 264, 1772-1775.
17. Hatefi Y. (1978) Preparation and properties of NADH: ubiquinone oxidoreductase (complex I), EC 1.6.5.3. Methods Enzymol. 53, 11-14.
18. Hirano A. (1991) Cytopathology in amyotrophic lateral sclerosis. Adv. Neurol. 56, 91-101.
19. Lai J. C. K. and Clark J. B. (1979) Preparation of synaptic and nonsynaptic mitochondria from mammalian brain. Methods Enzymol. 55, 51-60.
20. MacMillan-Crow L. A., Crow J. P., Kerby J. D., Beckman J. S., and Thompson J. A. (1996) Nitration and inactivation of manganese Superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. USA 93, 11853-11858.
21. Masui Y., Mozai T., and Kakehi K. (1985) Functional and morphometric study of the liver in motor neuron disease. J. Neurol 232, 15-19.
22. Misra H. P. and Fridovich I. (1972) The univalent reduction of oxygen by reduced flavins and quinones. J. Biol. Chem. 247, 188-192.
23. Mulder D. W., Kurland L. T., Offord K. P., and Beard C. M. (1986) Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36, 511-517.
24. Mutisya E. M., Bowling A. C., and Beal M. F. (1994) Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63, 2179-2184.
25. Nakano R., Sato S., Inusuka T., Sakimura K., Mishina M., Takahashi H., Ikuta F., Nomna Y., Fujii J., Taniguchi N., and Tsuji S. (1994) A novel mutation in Cu/Zn Superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 200, 695-703.
26. Rainero I. (1994) SOD1 missense mutation in an Italian family with ALS. Neurology 4, 347-349.
27. Robberecht W., Sapp P., Viaene M. K., Rosen D., McKenna-Yasek D., Haines J., Horvitz R., Theys P., and Brown R. Jr. (1994) Cu/Zn Superoxide dismutase activity in sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 62, 384-387.
28. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Van der Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R., and Brown R. H. Jr. (1993) Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
29. Rothstein J. D., Martin L. J., and Kuncl R. W. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 236, 1464-1468.
30. Rothstein J. D., Jin L., Dykes-Hoberg M., and Kuncl R. W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 6591-6595.
31. Rouleau G. A., Clark A. W., Rooke K., Pramatarova A., Krizus A., Suchowersky O., Julien J.-P., and Figlewicz D. (1996) SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol. 39, 128-131.
32. Sasaki S. and Iwata M. (1996a) Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 204, 53-56.
33. Sasaki S. and Iwata M. (1996b) Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 47, 535-540.
34. Sasaki S., Maruyama S., Yamane K., Sakuma H., and Takeishi M. (1990) Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease. J. Neurol. Sci. 97, 233-240.
35. Shepherd D. and Garland P. B. (1969) Citrate synthase from rat liver. Methods Enzymol. 13, 11-16.
36. Shibata N., Hirano A., Kobayashi M., Siddique T., Deng H.-X., Hung W.-Y., Kato T., and Asayama K. (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 55, 481-490.
37. Siddique T., Figlewicz D. A., Pericak-Vance M. A., Haines J. L., Rouleau G., Jeffers A. J., Sapp P., Hung W., Bebout J., McKenna-Yasek D., Deng G., Horvitz H. R., Gusella J. F., Brown R. H. Jr., and Roses A. D. (1991) Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic locus heterogeneity. N. Engl. J. Med. 324, 1381-1384.
38. Siklos L., Engelhardt J., Harati Y., Smith R. G., Joó F., and Appel S. H. (1996) Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann. Neurol. 39, 203-219.
39. Swerdlow R. H., Parks J. K., Miller S. W., Davis R. F., Pattee G., and Parker W. D. (1996) Evidence of genetic mitochondrial pathology in sporadic amyotrophic lateral sclerosis. Soc. Neurosci. Abstr. 22, 2413.
40. Tandan R. and Bradley W. G. (1985) Amyotrophic lateral sclerosis: part 1. Clinical features, pathology, and ethical issues in management. Ann. Neurol. 184, 271-280.
41. Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S., and Bredesen D. E. (1996) Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518.
42. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W., and Price D. L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.
43. m for hydrogen peroxide. Proc. Natl. Acad. Sci. USA 93, 5709-5714.
44. Zheng X., Shoffner J. M., Lott M. T., Voljavec A. S., Krawiecki N. S., Winn K., and Wallace D. C. (1989) Evidence in a lethal infantile mitochondrial disease for a nuclear mutation affecting the respiratory complexes I and IV. Neurology 39, 1203-1209.